Register Now
Why register?
 The leading web portal for pharmacy resources, news, education and careers November 20, 2017
Pharmacy Choice - Pharmacy News - November 20, 2017

Pharmacy News

Today's Pharmaceutical and Pharmacy News
Daily News Topic:

FDA News
11/20/17 - Batu Biologics Receives FDA Clearance for First Multi-Pronged Immunotherapy Targeting the Blood Vessels that Feed Cancer
By a News Reporter-Staff News Editor at Cancer Vaccine Week-- Batu Biologics, an immuno-oncology company dedicated to the development of its tumor-angiogenesis targeting immune therapy, ValloVaxâ?¢, has received an Investigational New Drug approval from the U.S. Food and Drug Administration allowing Batu to proceed with Phase 1 clinical trials.
11/20/17 - Biocon rallies 4% after Bengaluru unit gets cleared by US FDA [India Infoline News Service]
The US FDA had audited the companyâ?? s aseptic drug facility between May 25 and June 3 The US Food and Drug Administration issued an Establishment Inspection Report in relation to the inspection of Bioconâ?? s Bengaluru unit. The US FDA had previously issued a report in which they issued 10 observations on Bioconâ?? s Bengaluru plant. Biocon Ltd i
11/20/17 - Chugai's ALK Inhibitor "Alecensa®" Approved for the Treatment of First Line Therapy on ALK-Positive Non-Small Cell Lung Cancer in the US
By a News Reporter-Staff News Editor at Pharma Business Week-- Chugai Pharmaceutical Co., Ltd. announced that Genentech Inc., a member of the Roche Group, obtained approval from the U.S. Food and Drug Administration, for Alecensa ® in the treatment of "anaplastic lymphoma kinase- positive metastatic non-small cell lung cancer". "In July 2014, Ale
11/20/17 - Cipla receives final approval for Generic Dacogen [India Infoline News Service]
Generic Dacogen vial is indicated for treatment of patients with myelodysplastic syndromes Cipla has announced that it has received final approval for its Abbreviated New Drug Application for Decitabine Injection 50 mg single-use sterile vial from the United States Food and Drug Administration to market a generic version of Otsuka America...
11/20/17 - Divi's Lab seen up as USFDA clears Vizag Unit-II [India Infoline News Service]
Shares of Divi's Laboratories is likely to gain in today's trade following the approval from the USFDA for its Vizag unit. Divi's Laboratories is likely to witness positive traction in the stock as the US Food and Drug Administration has cleared the company's unit-II in Vishakhapatnam, Andhra Pradesh. In the last trading session, Divis Laboratories
11/20/17 - Emergent BioSolutions Receives FDA Approval to Manufacture ACAM2000 at Canton, Massachusetts Facility
--Emergent BioSolutions Inc. today announced that the U.S. Food and Drug Administration has approved the supplemental Biologics License Application for the manufacture of ACAM2000 ®, in the companyâ?? s newly-acquired cGMP live viral manufacturing facility in Canton, Massachusetts. â??Finalizing and receiving FDA licensure for the tech transfer of

Chain Drug Review
Chain Drug Review Magazine Chain Drug Review, established in 1978 and published 21 times a year, is recognized as the premier news publication serving the entire chain drug store industry.
Featured Article from Chain Drug Review:
AWP suit settlement appealed
The National Association of Chain Drug Stores has appealed a U.S. District Court’s approval of settlements in the First DataBank Inc. and Medi-Span Inc. lawsuit. »read more

Pharmacy News Index
  Drug Delivery Systems
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry


Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
Pharmacy Spanish
This lesson is supported by:

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...

Websites »
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement